New 4-in-1 shot for kids enters final testing phase

NCT ID NCT07406360

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study is testing a new combined vaccine against measles, mumps, rubella, and chickenpox (varicella) in healthy children. Researchers want to see if this new vaccine works as well as and is as safe as an existing licensed vaccine when given as a second dose. The study will involve about 1,200 children aged 15 months to 6 years who have already received their first dose of these vaccines.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEASLES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.